10.3390/ijms22062973 Int J Mol Sci
(PubMed) Maglione E, Marrese C, Migliaro E, et al
This might be explain with the presence of increased intracellular adenosine (uric acid precursor), a derivative of higher AMP concentrations due to increased synthesis of fatty acid-acyl-CoA in peripheral tissues (79), and the authors propose that in early obesity increased levels of uric acid are related to elevated plasma fatty acids
doi: 10.1016/j.foodchem.2012.08.003 392 FerreiraFDMossiniSAGFerreiraFMDArrotiaCCda CostaCLNakamuraCVet al
PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
As a powerful antioxidant supplement, it helps neutralize free radicals, supporting essential cell renewal and detoxifying the body
